Design, Synthesis, and Characterization of a Paclitaxel Formulation Activated by Extracellular MMP9.
Daniel EhrsamSandro SieberMouhssin OufirFabiola PortaMatthias HamburgerJoerg HuwylerHenriette E Meyer Zu SchwabedissenPublished in: Bioconjugate chemistry (2020)
taken together, we confirmed increased MMP9 in several cancer tissues (cervical, esophageal, lung, and brain) compared to healthy tissue and showed the effectiveness of MMP9-labile prodrug in in vitro tests.